Third Party Payor Agreements

Federal

• NIHB-New Product Listing- Shingrix (Jan 11, 2021)
• NIHB Pharmacy - COVID-19 FAQ (March 20, 2020)
• NHIB Prior Approval of Pharmacy Claims (March 20, 2020)
• NIHB Fee Increase Effective August 1, 2019
• NIHB Fee Increase Effective April 15, 2019
• NIHB One-time Fee Increase Effective June 1st, 2018
• NIHB Dispensing Fee Increase - Effective April 15, 2016
• Change to Listing Status of Suboxone (buprenorphine/naloxone)
• Citizenship and Immigration Canada – Client Eligibility
• Coordination of Benefits – Information for NIHB Providers
• Extemporaneous Mixture Policy – Effective November 4, 2013
• Drug Benefit List 2017
• Joint Statement on Faxed Prescriptions July 09
• NIHB List of Codeine DIN’s
• Modification to Pharmacy and MSE Provider Information Form
• NIHB Audit Tool Kit for Manitoba Pharmacists
• NIHB Pharmacy Claims Submission Kit
• NIHB Pharmacy Claims Submission Kit Attachments
• NIHB Short Term Dispensing Policy
• NIHB Questions and Answers Regarding Coordination of Benefits
• Pharmacy Provider Agreement

Provincial

• MHSAL Letter re EDS Extension (March 20, 2020)
• Pharmacare Dispensing Fee Cap Information - For Healh Professionals
• MHHLS Vaccine Reporting
• PCH Agreement 2017
• MPI Direct Billing of Prescription or OTC medications for Injury Claimants 
• Methadone Reimbursement Procedure – Updated January 15, 2015
• Methadone Reimbursement Procedure - Updated October 9, 2014
• Methadone Reimbursement Procedure
• Social Allowance Agreement

• Procedure for Billing Blood Glucose Test Strips (BGTS) Provincial Drug Programs